These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 8750713)

  • 21. Effect of cionin on histamine and acid secretion by the perfused rat stomach.
    Mårvik R; Johnsen AH; Rehfeld JF; Sandvik A; Waldum HL
    Scand J Gastroenterol; 1994 Jul; 29(7):591-4. PubMed ID: 7524136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct receptors for cholecystokinin and gastrin on canine fundic D-cells.
    DelValle J; Chiba T; Park J; Yamada T
    Am J Physiol; 1993 May; 264(5 Pt 1):G811-5. PubMed ID: 8098910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Both CCK-A and CCK-B/gastrin receptors mediate pepsinogen release in guinea pig gastric glands.
    Lin CW; Bianchi BR; Miller TR; Witte DG; Wolfram CA
    Am J Physiol; 1992 Jun; 262(6 Pt 1):G1113-20. PubMed ID: 1616041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of carbachol and gastrin on 14C-aminopyrine accumulated in rabbit gastric glands and cells.
    Romell B; Girma K; Seensalu R; Nilsson G
    Scand J Gastroenterol; 1993 Jun; 28(6):545-50. PubMed ID: 7686687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion.
    Sandvik AK; Waldum HL
    Am J Physiol; 1991 Jun; 260(6 Pt 1):G925-8. PubMed ID: 1711780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.
    Hernando F; Fuentes JA; Fournié-Zaluski MC; Roques BP; Ruiz-Gayo M
    Eur J Pharmacol; 1996 Dec; 318(2-3):221-9. PubMed ID: 9016909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula.
    Takemoto Y; Yuki H; Nishida A; Ito H; Kobayashi-Uchida A; Takinami Y; Akuzawa S; Ohta M; Satoh M; Semple G; Miyata K
    Arzneimittelforschung; 1998 Apr; 48(4):403-7. PubMed ID: 9608884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa--I. Characterization by means of agonists.
    Roche S; Gusdinar T; Bali JP; Magous R
    Biochem Pharmacol; 1991 Jul; 42(4):765-70. PubMed ID: 1714275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
    Patel S; Smith AJ; Chapman KL; Fletcher AE; Kemp JA; Marshall GR; Hargreaves RJ; Ryecroft W; Iversen LL; Iversen SD
    Mol Pharmacol; 1994 Nov; 46(5):943-8. PubMed ID: 7969084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
    Zavros Y; Shulkes A
    J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
    Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial agonism, neutral antagonism, and inverse agonism at the human wild-type and constitutively active cholecystokinin-2 receptors.
    Foucaud M; Tikhonova IG; Langer I; Escrieut C; Dufresne M; Seva C; Maigret B; Fourmy D
    Mol Pharmacol; 2006 Mar; 69(3):680-90. PubMed ID: 16293711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands.
    Attoub S; Moizo L; Laigneau JP; Alchepo B; Lewin MJ; Bado A
    Fundam Clin Pharmacol; 1998; 12(3):256-62. PubMed ID: 9646057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrin and CCK-8 induce inositol 1,4,5-trisphosphate formation in rabbit gastric parietal cells.
    Roche S; Magous R
    Biochim Biophys Acta; 1989 Dec; 1014(3):313-8. PubMed ID: 2557925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice.
    Hernando F; Fuentes JA; Roques BP; Ruiz-Gayo M
    Eur J Pharmacol; 1994 Aug; 261(3):257-63. PubMed ID: 7813546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties.
    Horwell DC; Hughes J; Hunter JC; Pritchard MC; Richardson RS; Roberts E; Woodruff GN
    J Med Chem; 1991 Jan; 34(1):404-14. PubMed ID: 1671419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa-II. Characterization by means of selective antagonists (L-364,718 and L-365,260).
    Roche S; Gusdinar T; Bali JP; Magous R
    Biochem Pharmacol; 1991 Jul; 42(4):771-6. PubMed ID: 1714276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of 125I-CCK-8 and 125I-gastrin-I to dispersed chief cells from guinea-pig stomach.
    Sutliff VE; Cherner JA; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1990 Apr; 1052(1):9-16. PubMed ID: 2322595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist.
    Dunlop J; Brammer N; Evans N; Ennis C
    Biochem Pharmacol; 1997 Jul; 54(1):81-5. PubMed ID: 9296353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.